Home
Conditions
Burkitt Lymphoma

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Completed

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

NCT00317785

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +48 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

NCT00003913

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 23 locations

View Trial Details

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

NCT00004157

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

NCT00255710

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00006042

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Burkitt Lymphoma

Burkitt Lymphoma trial results

Related conditions